Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Compare Drugs in Cytochrome P450 2C9 Inhibitors [MoA]

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
Drug Reports Deaths Death Rate Hosp. Life-Threat. Avg Age % Female
AMIODARONE 25,143 3,845 15.3% 13,711 3,889 69.9 yrs 36.9%
CANNABIDIOL 18,243 1,563 8.6% 5,149 104 21.6 yrs 45.2%
FLUCONAZOLE 15,157 2,546 16.8% 5,821 1,494 51.5 yrs 55.9%
VORICONAZOLE 14,384 3,940 27.4% 5,118 1,095 52.8 yrs 38.3%
AVAPRITINIB 10,117 302 3.0% 942 24 62.4 yrs 56.5%
REGORAFENIB 9,441 1,869 19.8% 3,363 271 62.2 yrs 39.9%
EFAVIRENZ 7,893 962 12.2% 1,528 252 40.7 yrs 37.7%
IVACAFTOR 6,735 291 4.3% 3,756 50 26.5 yrs 57.1%
CERITINIB 2,796 786 28.1% 804 84 55.6 yrs 55.1%
ETRAVIRINE 1,969 257 13.1% 405 74 47.5 yrs 33.5%

Head-to-Head Comparisons

AMIODARONE vs CANNABIDIOL AMIODARONE vs FLUCONAZOLE AMIODARONE vs VORICONAZOLE AMIODARONE vs AVAPRITINIB CANNABIDIOL vs FLUCONAZOLE CANNABIDIOL vs VORICONAZOLE CANNABIDIOL vs AVAPRITINIB FLUCONAZOLE vs VORICONAZOLE FLUCONAZOLE vs AVAPRITINIB VORICONAZOLE vs AVAPRITINIB
← Back to Cytochrome P450 2C9 Inhibitors [MoA] Class side effects →